Prof. Dr. Rodolfo de Paula Vieira is a Brazilian scientist specializing in pulmonary immunology, exercise physiology, and clinical nutrition. He is Head of the Laboratory of Pulmonary and Exercise Immunology (LABPEI) and founder of the Brazilian Institute for Teaching and Research in Pulmonary and Exercise Immunology (IBEPIPE).
His research focuses on the interaction between exercise, immune response, and chronic respiratory diseases, particularly COPD, asthma, interstitial lung diseases, and post-COVID-19 cardiopulmonary dysfunction. He leads both experimental and clinical studies investigating immunomodulatory strategies, including bioactive proteins, creatine, collagen peptides, phytotherapeutics, and structured exercise programs.
Prof. Vieira has extensive experience in murine models of pulmonary inflammation, clinical trials, cytokine profiling, and cardiopulmonary assessment. His work emphasizes systemic–pulmonary immune crosstalk and translational approaches that bridge laboratory findings to clinical application. He collaborates internationally and is actively involved in scientific mentoring, peer review, and research innovation.
Prof. Dr. Rodolfo de Paula Vieira is a Brazilian scientist specializing in pulmonary immunology, exercise physiology, and clinical nutrition. He is Head of the Laboratory of Pulmonary and Exercise Immunology (LABPEI) and founder of the Brazilian Institute for Teaching and Research in Pulmonary and Exercise Immunology (IBEPIPE).
His research focuses on the interaction between exercise, immune response, and chronic respiratory diseases, particularly COPD, asthma, interstitial lung diseases, and post-COVID-19 cardiopulmonary dysfunction. He leads both experimental and clinical studies investigating immunomodulatory strategies, including bioactive proteins, creatine, collagen peptides, phytotherapeutics, and structured exercise programs.
Prof. Vieira has extensive experience in murine models of pulmonary inflammation, clinical trials, cytokine profiling, and cardiopulmonary assessment. His work emphasizes systemic–pulmonary immune crosstalk and translational approaches that bridge laboratory findings to clinical application. He collaborates internationally and is actively involved in scientific mentoring, peer review, and research innovation.